Bavarian Nordic raises its expectations for the financial result for 2022 after contracts for monkeypox vaccine

Bavarian Nordic Enters First Larger Vaccine Contract with Government in Response to Monkeypox Outbreak

Bavarian is the only company in the world with a vaccine approved against the monkeypox virus.

They are now reporting to the stock exchange higher earnings for the year out and that they are in talks with several countries for their vaccine.

https://www.bavarian-nordic.com/investor/news/news.aspx?news=6578

https://finance.yahoo.com/chart/BAVA.CO